(3-(2-Chloropyrimidin-4-yl)phenyl)methanol

Catalog No.: 
ACTKZY513
CAS No.: 
859517-90-1
Molecular Formula: 
C11H9ClN2O
Molecular Weight: 
220.66
(3-(2-Chloropyrimidin-4-yl)phenyl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.001 week1 week
250mg95%$715.001 week1 week
1g95%$2008.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-(2-Chloropyrimidin-4-yl)phenyl)methanol
IUPAC Name(3-(2-chloropyrimidin-4-yl)phenyl)methanol
MDL No.MFCD09861464
Molecular FormulaC11H9ClN2O
Molecular Weight220.66
SMILESClC1=NC=CC(C2=CC(CO)=CC=C2)=N1
InChI KeyOKUZPLMHADFIMS-UHFFFAOYSA-N
Synonym[3-(2-Chloro-pyrimidin-4-yl)-phenyl]-methanol;PACR-013;3-(2-chloro-4-pyrimidinyl)-Benzenemethanol;3-(2-Chloro-4-pyrimidinyl)benzyl Alcohol;Benzenemethanol, 3-(2-chloro-4-pyrimidinyl)-
CAS No.859517-90-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTKZY513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEQGP632 route compound structure diagram
    ACEQGP63287199-15-3In Stock
  4. Then
  5. ACTKZY513 route product structure diagram
    ACTKZY513859517-90-1
Inquiry

2. ACTKZY513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKZY513 route product structure diagram
    ACTKZY513859517-90-1
Inquiry

3. ACTKZY513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKZY513 route product structure diagram
    ACTKZY513859517-90-1
Inquiry

Comments (0)